Medical Device Distribution Agreements

A medical device distribution agreement can look straightforward until the first problem hits. Founders and growing businesses often sign supplier paper that does not clearly deal with TGA responsibilities, product recalls, territory restrictions or who carries the risk when a device causes loss. Another common mistake is relying on sales conversations instead of checking what the contract actually says about exclusivity, stock returns and minimum purchase targets. A third is accepting broad indemnities without understanding how they interact with Australian Consumer Law and product liability risk.

If you are appointing a distributor, becoming one, or expanding an existing device line in Australia, the contract needs to do more than record pricing. It should spell out who can sell, where they can sell, what claims can be made about the device, and what happens if supply is interrupted or regulators step in. Here’s what this guide answers, the key legal terms to review, the practical issues that matter before you sign, and the mistakes that commonly create disputes later.

Overview

A medical device distribution agreement is the contract between the supplier or manufacturer and the business authorised to market, promote, store or sell the device in Australia. In practice, it sits at the centre of your supply chain, regulatory compliance and commercial risk allocation.

The best agreements are clear about who does what, who carries which liabilities, and what happens if demand, regulation or product performance changes. That matters even more in the medical device sector, where advertising rules, quality controls and recall obligations can have immediate commercial consequences.

Identify the exact devices covered, including versions, accessories and future products.
Confirm whether the appointment is exclusive, sole or non-exclusive, and define the territory and sales channels.
Allocate regulatory responsibilities, including TGA listing or inclusion issues, record keeping, complaint handling and adverse event reporting.
Set pricing, minimum order levels, forecasting, stock holding requirements and payment terms.
Deal with product warranties, indemnities, liability clauses, insurance obligations, Australian Consumer Law exposure and product liability risk.
Include clear rules for marketing claims, training, use of brand assets and approval of promotional materials.
Set out recall procedures, defective stock processes, returns and replacement obligations.
Explain termination rights, post-termination sell-off, transition of customers and handling of unsold stock.

What Medical Device Distribution Agreement Means For Australian Businesses

A medical device distribution agreement is not just a supply contract, it is the document that decides how a regulated product reaches the Australian market and who wears the risk when something goes wrong.

For an Australian manufacturer or sponsor, the agreement is how you control market access without employing your own sales force in every channel. For a distributor, it is the document that determines whether you really have protected territory, reliable margins and a workable set of compliance obligations.

Why this agreement matters more for medical devices

Medical devices are not ordinary retail goods. Depending on the product, there may be TGA classification issues, inclusion on the Australian Register of Therapeutic Goods, advertising restrictions, post-market monitoring obligations and technical storage or handling requirements.

If the contract is vague, each side can assume the other is taking care of compliance. That is where founders often get caught. A supplier may assume the distributor will only use approved marketing language, while the distributor assumes all claims made in the sales pack are already legally cleared.

Who usually signs this type of agreement

The parties vary, but common structures include:

An overseas manufacturer appointing an Australian distributor.
An Australian sponsor appointing a local wholesaler or specialist distributor.
A manufacturer appointing separate distributors for hospital, pharmacy, aged care or online channels.
A head distributor appointing sub-distributors, if the upstream contract allows it.

Each structure changes the legal drafting. For example, an Australian sponsor may carry direct TGA-facing responsibilities that need to be reflected in the contract, while a pure logistics distributor may need narrower obligations.

What the agreement normally covers

The legal terms should match the real commercial arrangement, not a recycled template. Most medical device distribution contracts deal with:

Appointment terms and scope of authority.
Territory and customer segments.
Supply mechanics, orders and delivery.
Pricing and rebates.
Storage, transport and quality controls.
Regulatory and compliance responsibilities.
Marketing approvals and use of intellectual property.
Warranties, indemnities and insurance.
Termination and post-termination consequences.

Before you sign a contract, compare those legal headings against your actual business model. If you are selling capital equipment to clinics with consumables and servicing attached, the agreement should not treat the arrangement like ordinary one-off wholesale supply.

Exclusive, sole or non-exclusive, the difference matters

Exclusivity disputes are common because parties use the word loosely in negotiations. The contract needs to define it precisely.

Exclusive usually means only the distributor can sell the covered devices in the defined territory or channel, and the supplier cannot appoint others or sell directly there.
Sole often means the distributor is the only appointed third party, but the supplier may still sell directly.
Non-exclusive means the supplier can appoint multiple distributors and may sell itself.

If your business plan depends on protected market access, do not rely on a verbal promise. The contract should also say what performance conditions must be met to keep that exclusivity.

Legal Issues To Check Before You Sign

The most important legal question before you sign is this, does the agreement clearly allocate commercial and regulatory responsibility in a way your business can actually comply with?

A one-sided agreement often looks acceptable until you test it against real founder moments, a product complaint arrives, a hospital customer delays payment, the supplier changes packaging, or the TGA raises a concern about advertising.

Product scope and specifications

The agreement should identify the products with enough detail to avoid argument later. That may include model numbers, intended use, approved claims, accessories, software elements and replacement parts.

If you expect future product releases to be included, say so expressly. Otherwise, the supplier may be free to appoint someone else for the next generation of the same device line.

Regulatory compliance and TGA responsibilities

The contract should state who is responsible for each regulatory function in Australia. That is especially important where one party manufactures, another is the Australian sponsor, and another handles customer-facing distribution.

Key areas to allocate clearly include:

Who maintains ARTG inclusion or related sponsor obligations, where relevant.
Who prepares, reviews and approves labels, instructions for use and promotional material.
Who handles complaint intake, adverse event escalation and regulator communications.
Who keeps distribution records and for how long.
Who manages storage, transport conditions and traceability.
Who leads and funds corrective actions, field safety notices and recalls.

If your business is the distributor, be careful about taking on broad compliance warranties that extend beyond your actual control. If the supplier controls technical documents and approved claims, the contract should reflect that.

Territory, channels and customer restrictions

The agreement should define exactly where and to whom the distributor can sell. Australia-wide rights are different from rights limited to a state, a hospital network, a clinical speciality or online channels.

Check whether the contract restricts sales into government tenders, ecommerce, export, marketplaces or direct approaches to key accounts. A distributor can lose much of the commercial value of the deal if those carve-outs are hidden in definitions or schedules.

Orders, supply and inventory risk

Supply terms decide whether the arrangement is commercially workable. The contract should explain how orders are placed, when they are accepted, what lead times apply, and what happens during shortages.

Pay close attention to:

Minimum purchase commitments and whether they are realistic.
Forecasting obligations and whether forecasts are binding.
Price change rights and notice periods.
Delivery terms, transfer of risk and title.
Backorder rules and allocation during supply constraints.
Expiry dating, shelf life and stock rotation obligations.

Before you spend money on setup, pressure-test the numbers. If the supplier can raise prices quickly but your distributor margins are fixed in customer contracts or tenders, the economics may fail fast.

Marketing, claims and brand control

Medical device advertising and promotional statements need close control. The agreement should say whether the distributor can prepare local marketing material, what prior approvals are required, and whether sales representatives can adapt product claims.

It should also cover use of trade marks, logos, product names and technical materials. If the supplier owns the branding, the contract should grant a limited licence for approved uses only, and require the distributor to stop using those assets when the agreement ends.

Warranties, indemnities and liability caps

This is where the commercial risk sits. The supplier may give product warranties, but the contract must also deal with who pays if a defect, misleading claim, storage failure or user injury results in a loss.

Points to negotiate include:

Whether product performance warranties are tied to approved specifications only.
Whether the distributor gives warranties about storage, handling, marketing conduct or compliance with instructions.
Which party indemnifies the other for product defects, regulatory breaches, third party claims or intellectual property infringement.
Whether liability caps apply, and which liabilities are carved out from the cap.
What insurance each party must hold, including product liability cover.

Be careful with broad indemnities that require one party to cover any loss connected with the arrangement. Those clauses can go much further than a founder expects.

Australian Consumer Law and product liability

No contract can simply contract out of all legal responsibility. Australian Consumer Law may imply guarantees in some supply chains, and product liability risks can still arise where goods cause injury or loss.

The contract should be drafted with those rules in mind. Standard exclusions copied from overseas templates may not fit the Australian position, especially where devices move through multiple hands before reaching clinical users or consumers.

Recall and defective product procedures

A recall clause should do more than say the supplier can recall products. It should set out the practical steps each party must follow if devices need to be withdrawn, corrected or replaced.

That usually includes:

Who decides whether a recall or corrective action is required.
Who communicates with customers, clinicians and regulators.
Who pays for freight, notifications, replacements and disposal.
How the parties cooperate on traceability and record retrieval.
How the parties handle media statements and reputational issues.

If the product sits in hospitals or clinics, traceability obligations are especially important.

Term, termination and exit planning

The exit clauses should make commercial sense before the relationship turns difficult. A distributor may spend heavily on market development, training and customer relationships, while the supplier may need the right to act fast if compliance concerns arise.

Review:

The initial term and renewal mechanism.
Termination for convenience, cause, insolvency or regulatory concerns.
Cure periods for breach.
Rights to sell remaining stock after termination.
Repurchase of inventory, demo units and marketing materials.
Transfer of customer information and open orders.

If there is no sensible exit framework, disputes often shift from legal interpretation to commercial pressure.

Common Mistakes With Medical Device Distribution Agreement

The most common mistake is treating a medical device distribution agreement like a standard wholesale template when the underlying product and compliance risks are much more specific.

That usually leads to avoidable gaps, especially when one party is moving quickly to secure a deal and assumes details can be fixed later.

Assuming the standard form is balanced

Supplier templates are usually written to protect the supplier. Distributor templates usually do the opposite. Neither should be accepted on the basis that the terms are “market standard” without checking the detail.

Founders often focus on price and territory first, then miss indemnities, performance triggers and termination rights buried near the back.

Leaving regulatory tasks implied

If the agreement does not state who handles complaints, adverse events, regulator correspondence and approved marketing claims, each side can point at the other once a problem arises.

Medical devices are not the place for implied assumptions. The contract should allocate operational responsibility line by line.

Agreeing to unrealistic sales targets

Exclusivity is often tied to minimum purchases or revenue targets. That can be reasonable, but not if the target ignores tender cycles, reimbursement settings, clinician adoption periods or product training lead times.

Before you sign, test the targets against realistic market conditions and supply reliability. Also check whether temporary shortages excuse non-performance.

Overlooking channel conflict

A distributor may think it has meaningful rights, then discover the supplier can sell direct to key accounts, appoint ecommerce resellers or carve out government contracts.

If channel strategy matters to your business case, spell it out. This is one of the most common causes of disappointment even where no one technically breached the contract.

Ignoring data and confidentiality issues

Customer lists, pricing information, sales reports and complaint records can be highly sensitive. If patient information or identifiable health information is ever handled, privacy obligations and data protection requirements may also come into play.

The agreement should deal with confidentiality, permitted disclosures, ownership of sales data and the handling of personal information. If the distributor uses a CRM or cloud platform, make sure the data-sharing expectations match how the system actually works.

Failing to plan for the end of the relationship

Parties usually negotiate hard at the start and barely discuss the end. That is a mistake when inventory, device servicing, warranties and customer continuity are involved.

A clean exit clause can prevent disputes over unsold stock, spare parts, support obligations and use of branding after termination.

FAQs

Does a medical device distribution agreement need to be exclusive?

No. It can be exclusive, sole or non-exclusive. The right model depends on your market strategy, the level of investment expected from the distributor and whether performance targets are achievable.

Who is responsible for TGA compliance, the supplier or the distributor?

It depends on the structure of the deal and each party’s role. The agreement should allocate specific responsibilities clearly rather than relying on general statements about compliance.

Can a distributor make its own marketing claims about a medical device?

Not safely unless the contract and approval process allow it, and the claims are legally and technically supportable. Marketing statements should usually be controlled and approved to avoid regulatory and misleading conduct risk.

What happens if a product recall is needed?

The contract should set out a recall process, including notification steps, customer communications, cost allocation, traceability and replacement arrangements. If it does not, a recall can become slow, expensive and contentious.

Can the parties limit liability in the agreement?

Often yes, but not in a way that overrides laws that cannot be excluded, and not always for every type of loss. Liability caps, carve-outs, indemnities and insurance should be reviewed together rather than as separate clauses.

Key Takeaways

A medical device distribution agreement should do more than record pricing and supply, it should allocate regulatory, operational and commercial risk clearly.
Before you sign, check product scope, territory, exclusivity, supply mechanics, marketing controls, warranties, indemnities, insurance and termination rights.
TGA-related responsibilities, complaint handling, adverse event reporting and recalls should be expressly assigned in the contract.
Australian Consumer Law and product liability risk still matter, even where the contract tries to limit responsibility.
The most expensive mistakes usually come from relying on verbal assurances, accepting broad standard terms, or failing to plan for shortages, recalls and the end of the relationship.

If you want help with contract review, exclusivity terms, TGA responsibility clauses, indemnities, and termination rights, you can reach us on 1800 730 617 or team@sprintlaw.com.au for a free, no-obligations chat.

Medical Device Distribution Agreements in Australia: Key Legal Terms